In minority women, healthy diet reduces risk of type 2 diabetes
the ONA take:
While consuming a healthy diet is associated with a lower risk of type 2 diabetes in women, it has the greatest benefit in women who are Asian, Hispanic or black, according to a recent study published in Diabetes Care.
Researchers led by Jinnie Rhee, MSc, of the Harvard School of Public Health analyzed patient data in women taken from the Nurses’ Health Study (I and II) -- 156,030 were non-Hispanic white, 2,026 Asian, 2,053 Hispanic, and 2,307 black. The women were followed for up to 28 years and were asked to fill out diet questionnaires every four years. They created a dietary diabetes risk reduction score that included components associated with type 2 diabetes risk, with a higher score indicating a healthier overall diet.
They found that there was a protective association between healthy overall diet and type 2 diabetes risk across all racial and ethnic groups. However, since minority women were initially at a higher risk of diabetes than white women, healthy diet was seen to prevent 8 cases for every 1,000 minority women compared to 5.3 for every 1,000 white women.
“As the incidence of type 2 diabetes continues to increase at an alarming rate worldwide, these findings can have global importance for what may be the largest public health threat of this century,” Dr. Rhee said.
It has the greatest benefit in women who are Asian, Hispanic or black.
- Ixazomib, a New PI, Offers Improved Efficacy With Acceptable Toxicity Profile for Relapsed/Refractory Multiple Myeloma
- Acupuncture May Improve Fatigue in Patients with Lung Cancer
- "Light" Cigarettes and Cancer Risk (Fact Sheet)
- A Review of CDK4/6 Toxicities and Interactions Management in Breast Cancer
- Vitamin D3 Supplementation Has No Impact on Breast Density Percentage, Breast Cancer Risk
- Dexamethasone-Induced Hiccups in Chemotherapy May be Prevented by Rotating to Methylprednisolone
- New Evidence Shows Metastases May Spread Independently of Lymph Nodes
- Long Term Survivors of Prostate Cancer Express Treatment Decision Regret for Up to 15 Years
- FDA Expands Clearance for Cooling Cap Use With Chemotherapy for Solid Tumors
- Recommendations for Vaccine Administration During Chemotherapy
- Risk for Prostate Cancer Not Associated With Vasectomy, Meta-analysis Affirms
- Disease-Free Survival After Breast Cancer Comparable With Exemestane, Sequential Tamoxifen/Exemestane
- Treating the Other "Patient": Depressive Symptoms Are Predictive of Declining Physical Health in Caregivers
- Oropharyngeal Mucositis Pain Effectively Relieved With Indomethacin Oral Spray
- Opioids Overprescribed in Patients Undergoing Surgery
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|